Xu L - Search Results

1

RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis.

Li M, Song D, Chen X, Wang X, Xu L, Yang M, Yang J, Kalvakolanu DV, Wei X, Liu X, Li Y, Guo B, Zhang L. Li M, et al. Among authors: xu l. Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166529. doi: 10.1016/j.bbadis.2022.166529. Epub 2022 Aug 27. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 36041715 Free article.

2

Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo.

Sun Y, Guo BF, Xu LB, Zhong JT, Liu ZW, Liang H, Wen NY, Yun WJ, Zhang L, Zhao XJ. Sun Y, et al. Among authors: xu lb. Cell Biochem Funct. 2015 Oct;33(7):495-502. doi: 10.1002/cbf.3148. Epub 2015 Oct 20. Cell Biochem Funct. 2015. PMID: 26486443

3

Plasmid-Based Stat3 siRNA Delivered by Functional Graphene Oxide Suppresses Mouse Malignant Melanoma Cell Growth.

Yin D, Li Y, Guo B, Liu Z, Xu Y, Wang X, Du Y, Xu L, Meng Y, Zhao X, Zhang L. Yin D, et al. Among authors: xu l, xu y. Oncol Res. 2016;23(5):229-36. doi: 10.3727/096504016X14550280421449. Oncol Res. 2016. PMID: 27098146 Free PMC article.

4

miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.

Xu L, Zhong J, Guo B, Zhu Q, Liang H, Wen N, Yun W, Zhang L. Xu L, et al. Tumour Biol. 2016 Sep;37(9):12023-12032. doi: 10.1007/s13277-016-5058-2. Epub 2016 May 11. Tumour Biol. 2016. PMID: 27164937

5

Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle‑delivered short hairpin RNAs against Stat3.

Liang Z, Wang H, Guo B, Li F, Liu J, Liu Z, Xu L, Yun W, Zhao X, Zhang L. Liang Z, et al. Among authors: xu l. Mol Med Rep. 2017 Jul;16(1):459-465. doi: 10.3892/mmr.2017.6583. Epub 2017 May 16. Mol Med Rep. 2017. PMID: 28534932

6

Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China.

Xu L, Wang J, Guo B, Zhang H, Wang K, Wang D, Dai C, Zhang L, Zhao X. Xu L, et al. Oncotarget. 2017 Sep 8;9(1):428-441. doi: 10.18632/oncotarget.20787. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416625 Free PMC article.

7

Synergistic Suppression of Melanoma Growth by a Combination of Natural dsRNA and Panaxadiolsaponins.

Zhao Y, Liu H, Xu L, Guo B, Kalvakolanu DV, Liu X, Hu J, Zhang D, Sun Y, Zhang L, Xu D, Zhao X. Zhao Y, et al. Among authors: xu l, xu d. J Interferon Cytokine Res. 2018 Sep;38(9):378-387. doi: 10.1089/jir.2018.0037. J Interferon Cytokine Res. 2018. PMID: 30230984

8

Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.

Wen N, Guo B, Zheng H, Xu L, Liang H, Wang Q, Wang D, Chen X, Zhang S, Li Y, Zhang L. Wen N, et al. Among authors: xu l. Int J Oncol. 2019 Oct;55(4):879-895. doi: 10.3892/ijo.2019.4863. Epub 2019 Aug 29. Int J Oncol. 2019. PMID: 31485609 Free PMC article.

9

SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.

Wang Q, Jia S, Jiao Y, Xu L, Wang D, Chen X, Hu X, Liang H, Wen N, Zhang S, Guo B, Zhang L. Wang Q, et al. Among authors: xu l. Int J Med Sci. 2019 Oct 21;16(12):1573-1582. doi: 10.7150/ijms.38439. eCollection 2019. Int J Med Sci. 2019. PMID: 31839745 Free PMC article.

10

RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7.

Liang H, Wang Q, Wang D, Zheng H, Kalvakolanu DV, Lu H, Wen N, Chen X, Xu L, Ren J, Guo B, Zhang L. Liang H, et al. Among authors: xu l. Biochem Pharmacol. 2020 Oct;180:114118. doi: 10.1016/j.bcp.2020.114118. Epub 2020 Jun 23. Biochem Pharmacol. 2020. PMID: 32585142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,813 results

Search Page